Finding novel differentially expressed genes in pancreatic cancer and understanding their role in biology holds the potential to improve pancreatic cancer diagnosis, prognosis and treatment, Anand said.
The new facility will increase patient access to advanced healthcare in west Mobile.
News at USA Health
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.
Menger fulfilled his oath as both a military and medical professional and headed to treat COVID-19 patients in New York City, which quickly was becoming the epicenter for the virus in the United States.
USA Health University Hospital has earned three of the American Heart Association/American Stroke Association Awards designed to recognize excellence in stroke care.
In addition to epilepsy, Yuliati will treat autism, headaches, concussions, traumatic brain injuries, brain tumors, vascular malformations and cerebral palsy with a special interest and research focus on neonatal seizures, neurocritical care and epilepsy surgery.
Pallavi Patil, M.D., was in her first year of medical school when a micrograph of cells captured her attention. The image, taken with a scanning electron microscope, generated her interest in studying the pathophysiology of disease.
Louis and Melinda Mapp have announced their intentions to donate approximately eight acres of land in Baldwin County to the University of South Alabama.
A recent discovery at the University of South Alabama College of Medicine shows there is a contributor in the body that helps fight viral infections.
Allen Broome, Pharm.D., has been named director of health system pharmacy for USA Health. In this position, Broome will oversee clinical and financial operations for USA Health’s pharmacies located at University Hospital, Children’s & Women’s Hospital and the Mitchell Cancer Institute.
Breakthrough technology is providing researchers at USA Health Mitchell Cancer Institute a more precise understanding of how cancer cells grow.
As the opioid crisis continues to impact communities across the world, a physician-scientist at USA Health has been named the principal investigator of an international phase II clinical trial to evaluate the safety of a drug for babies born with neonatal opioid withdrawal syndrome.